CAR T-Cell Therapy
Helping families understand how immunotherapy fights cancer cells
Project Background
Chimeric antigen receptor (CAR) T-cell therapy uses gene-edited lymphocytes to bind to specific cancer cell antigens. It can be used to treat leukemia and lymphoma that do not respond to other therapies. A children’s research hospital asked us to help explain this treatment to families.
Client: Children’s Hospital
Our Work
We designed anthropomorphized cell characters grounded in scientific accuracy. In the sequence of images, the T-Cell character is enhanced with new chimeric antigen receptor (CAR) arms that help it grab and destroy cancer cells.
Illustration for article on CAR T-Cell Therapy
Illustration for article on CAR T-Cell Therapy
Results
The images are embedded with an article on the patient education website of the children’s research hospital.
